Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft vs. Host Disease (GvHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02067832
What this trial is testing

Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft vs Host Disease
University of British Columbia 302
Post-approval studies (Phase 4)UnknownNCT06149832
What this trial is testing

Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing

Who this might be right for
Mesenchymal Stem Cells
Southwest Hospital, China 38
Not applicableUnknownNCT00093587
What this trial is testing

Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Not applicableUnknownNCT04850963
What this trial is testing

Effects of Dualsite Anodic tDCS on Lower Limbs Function in Patients After Stroke: Randomized, Double-blind, Placebo-controlled, Crossover Trial

Who this might be right for
Stroke, Chronic
Federal University of Paraíba 40
Testing effectiveness (Phase 2)Looking for participantsNCT06299462
What this trial is testing

PTCy and ATG for MSD and MUD Transplants

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+2 more
Instituto Nacional de Cancer, Brazil 50
Not applicableUnknownNCT00017654
What this trial is testing

Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia

Who this might be right for
Graft Versus Host DiseaseAplastic Anemia
Northwestern Memorial Hospital 3
Post-approval studies (Phase 4)Study completedNCT05294666
What this trial is testing

Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment

Who this might be right for
Graft Versus Host Disease in Eye
Peking University Third Hospital 89
Testing effectiveness (Phase 2)Study completedNCT03483675
What this trial is testing

Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00886522
What this trial is testing

Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

Who this might be right for
Hematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 23
Testing effectiveness (Phase 2)Study completedNCT02195869
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Pharmacyclics LLC. 45
Testing effectiveness (Phase 2)Study completedNCT02824653
What this trial is testing

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

Who this might be right for
Graft Versus Host Disease
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 10
Early research (Phase 1)Study completedNCT02728895
What this trial is testing

Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Takeda 24
Not applicableStudy completedNCT02633215
What this trial is testing

Enhancing Plasticity in Stroke Patients With Severe Motor Deficit

Who this might be right for
StrokeCerebrovascular Accident
Lumy Sawaki 36
Not applicableEnded earlyNCT05333978
What this trial is testing

Optoacoustic Detection of Inflammation Using MSOT Device

Who this might be right for
Graft Vs Host DiseaseColitisCrohn Disease
University of Oklahoma 29
Testing effectiveness (Phase 2)Study completedNCT01025778
What this trial is testing

Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Lund University Hospital 7
Not applicableStudy completedNCT02085798
What this trial is testing

Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)

Who this might be right for
Myelodysplastic SyndromeLeukemia, Myelomonocytic, Chronic
Celgene 503
Post-approval studies (Phase 4)UnknownNCT06066840
What this trial is testing

Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement

Who this might be right for
Safety and Efficacy
The First Affiliated Hospital of Soochow University 45
Early research (Phase 1)Study completedNCT00004904
What this trial is testing

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Northwestern University
Large-scale testing (Phase 3)Study completedNCT01186744
What this trial is testing

Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 666
Next Page